West Chester, PA, United States of America

Magdalena Zalacain

This inventor holds 45 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Biochemical Compounds. Top assignees: Smithkline Beecham Corporation, Antabio Sas, Other. Active years: 1999-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Magdalena Zalacain. Retrieved from https://idiyas.com/inventor/magdalena-zalacain

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 80(Granted Patents)

Location History:

King of Prussia, PA (US) (2003)
West Chester, PA (US) (1999 - 2022)

Company Filing History:

46 out of 2,198

Smithkline Beecham Corporation

4 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2022

Loading Chart...

Areas of Expertise:

Chemical Compounds

Peptidyl t-RNA Hydrolase

Ornithine Carbamoyltransferase

Fucose Kinase

Histidine Kinase

Nucleic Acid

Response Regulator

tRNA Methyltransferase

Polynucleotides

Adenine Phosphoribosyltransferase

Streptococcus pneumoniae

Sensor Histidine Kinase

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11299467 - Chemical compounds (2022-04-12),

2. 7202071 - Peptidyl t-RNA hydrolase (PTH) (2007-04-10),

3. 6706508 - Ornithine carbamoyltransferase (2004-03-16),

4. 6558919 - AmpS from Streptococus pneumoniae (2003-05-06),

5. 6548273 - lacR from Streptococcus pneumoniae (2003-04-15),

6. 6511839 - Fucose kinase (2003-01-28),

7. 6399343 - inFB (2002-06-04),

8. 6352843 - YsxC from Staphylococcus aureus (2002-03-05),

9. 6350600 - trmD (2002-02-26),

10. 6348578 - Apt (2002-02-19),

11. 6340564 - yhxB (2002-01-22),

12. 6326172 - ytgP (2001-12-04),

13. 6316211 - ThdF (2001-11-13),

14. 6303771 - Pth (2001-10-16),

15. 6297039 - Amps from Streptococcus pneumoniae (2001-10-02),

Certainly! Here is an article about the inspiring inventor Magdalena Zalacain:

Title: Magdalena Zalacain: Pioneering Innovation in West Chester

Introduction:

Magdalena Zalacain is a trailblazing inventor whose dedication to pushing the boundaries of innovation continues to inspire the next generation of inventors. Based in West Chester, PA, her remarkable journey in the field of technology has led to groundbreaking advancements with a total of 45 patents to her name.

Latest Patents:

Among her latest patents, Magdalena Zalacain has introduced revolutionary advancements in the field of chemical compounds. One notable invention is a thiazole derivative compound that has shown efficacy in the treatment and prevention of bacterial infections. Additionally, her work on Peptidyl t-RNA hydrolase (PTH) has paved the way for novel screening methods for antibacterial compounds.

Career Highlights:

Throughout her prolific career, Magdalena Zalacain has made significant contributions to various companies. She has showcased her innovative prowess at SmithKline Beecham Corporation, where her visionary ideas have left a lasting impact on the industry. Her dedication to research and development has been instrumental in shaping the landscape of technology.

Collaborations:

Magdalena Zalacain's collaborative spirit has been a driving force behind her success. She has had the privilege of working alongside esteemed colleagues such as Sanjoy Biswas and James Raymond Brown. These collaborations have not only fostered innovation but have also laid the foundation for transformative breakthroughs in the field.

Conclusion:

In conclusion, Magdalena Zalacain's passion for innovation and relentless pursuit of excellence have established her as a true pioneer in the world of technology. Her work continues to inspire and influence the next generation of inventors, setting a high standard for creativity and ingenuity in the industry. Magdalena Zalacain's legacy serves as a testament to the power of innovation in shaping a brighter future for us all.

Profile summary based on public USPTO records.